Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibitory effects of parathyroid hormone on growth of osteogenic sarcoma cells.

Literature DB >> 3933791

Inhibitory effects of parathyroid hormone on growth of osteogenic sarcoma cells.

N C Partridge, A L Opie, R T Opie, T J Martin.

Abstract

The effects of the bone resorbing hormone, parathyroid hormone (PTH), on the growth of malignant osteoblastic cells have been examined. The malignant osteoblastic cells were a clonal line (UMR 106) derived from a transplantable rat osteogenic sarcoma. The predominant effect of PTH at doses above 10(-10) M was an inhibition of replication and DNA synthesis. Replication was decreased by PTH in both the presence or absence of serum and at various cell seeding densities. Both bovine PTH (1-84) and the synthetic hormone, human PTH (1-34), inhibited replication, but with bovine hormone being an order of magnitude more potent. The effects could be observed in as short a time as 6 hours with DNA synthesis and 24 hours with replication.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 1985 PMID： 3933791 DOI： 10.1007/bf02557835

Source DB: PubMed Journal: Calcif Tissue Int ISSN： 0171-967X Impact factor: 4.333

24 in total

1. Metabolic properties of hormonally responsive osteogenic sarcoma cells.

Authors: T J Martin; P M Ingleton; L A Coulton; R A Melick
Journal: Clin Orthop Relat Res Date: 1979-05 Impact factor: 4.176

Review 2. Role of cyclic nucleotides in growth control.

Authors: I H Pastan; G S Johnson; W B Anderson
Journal: Annu Rev Biochem Date: 1975 Impact factor: 23.643

3. Experimental study of changes in osteoblastic shape induced by calcitonin and parathyroid extract in an organ culture system.

Authors: S J Jones; A Boyde
Journal: Cell Tissue Res Date: 1976-07-06 Impact factor: 5.249

Review 4. Type I cyclic AMP-dependent protein kinase as a positive effector of growth.

Authors: D H Russell
Journal: Adv Cyclic Nucleotide Res Date: 1978

5. Growth control and cyclic alterations of cyclic AMP in the cell cycle.

Authors: M M Burger; B M Bombik; B M Breckenridge; J R Sheppard
Journal: Nat New Biol Date: 1972-10-11

6. Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors.

Authors: J S Bertram; B B Bertram; P Janik
Journal: J Cell Biochem Date: 1982 Impact factor: 4.429

7. Increases in cyclic AMP potentiate competence formation in BALB/c-3T3 cells.

Authors: W Wharton; E B Leof; N Olashaw; H S Earp; W J Pledger
Journal: J Cell Physiol Date: 1982-05 Impact factor: 6.384

8. Intermediate role of adenosine 3':5'-cyclic monophosphate and protein kinase during gonadotropin-induced steroidogenesis in testicular interstitial cells.

Authors: M L Dufau; T Tsuruhara; K A Horner; E Podesta; K J Catt
Journal: Proc Natl Acad Sci U S A Date: 1977-08 Impact factor: 11.205

9. Synergistic stimulation of DNA synthesis by cyclic AMP derivatives and growth factors in mouse 3T3 cells.

Authors: E Rozengurt
Journal: J Cell Physiol Date: 1982-08 Impact factor: 6.384

10. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.

Authors: K W Ng; S A Livesey; R G Larkins; T J Martin
Journal: Cancer Res Date: 1983-02 Impact factor: 12.701

15 in total

Review 1. Stemming bone loss by suppressing apoptosis.

Authors: J M Hock
Journal: J Clin Invest Date: 1999-08 Impact factor: 14.808

2. Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01).

Authors: D J McQuillan; D M Findlay; A M Hocking; M Yanagishita; R J Midura; V C Hascall
Journal: Biochem J Date: 1991-07-01 Impact factor: 3.857

3. Teriparatide (human PTH_1-34) compensates for impaired fracture healing in COX-2 deficient mice.

Authors: Kiminori Yukata; Chao Xie; Tian-Fang Li; Matthew L Brown; Tsukasa Kanchiku; Xinping Zhang; Hani A Awad; Edward M Schwarz; Christopher A Beck; Jennifer H Jonason; Regis J O'Keefe
Journal: Bone Date: 2018-02-03 Impact factor: 4.398

4. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.

Authors: T Ishizuya; S Yokose; M Hori; T Noda; T Suda; S Yoshiki; A Yamaguchi
Journal: J Clin Invest Date: 1997-06-15 Impact factor: 14.808

5. Plasma-membrane-intercalated heparan sulphate proteoglycans in an osteogenic cell line (UMR 106-01 BSP).

Authors: D J McQuillan; R J Midura; V C Hascall; M Yanagishita
Journal: Biochem J Date: 1992-07-01 Impact factor: 3.857

6. Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin.

Authors: L R Chaudhary; L V Avioli
Journal: Mol Cell Biochem Date: 1998-01 Impact factor: 3.396

10. Time-dependent effects of parathyroid hormone and prostaglandin E2 on DNA synthesis by periosteal cells from embryonic chick calvaria.

Authors: A Scutt; C Duvos; J Lauber; H Mayer
Journal: Calcif Tissue Int Date: 1994-09 Impact factor: 4.333